Admitted local publications that cite Neutralizing antibodies and safety of a COVID-19 vaccine against SARS-CoV-2 wild-type and Omicron variants in solid cancer patients.
No admitted local citation edges point to this work yet.
Cited by — Neutralizing antibodies and safety of a COVID-19 vaccine against SARS-CoV-2 wild-type and Omicron variants in solid cancer patients | ResearchHub - ResearchHub
